Standout Papers
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study (2013)
- Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial (2019)
- Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis (2020)
Immediate Impact
6 from Science/Nature 79 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Applied body-fluid analysis by wearable devices
2024 StandoutNature
Works of Ahmed A. Othman being referenced
A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy
2016
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
2013 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ahmed A. Othman | 319 | 374 | 351 | 613 | 517 | 91 | 2.6k | |
| Kathryn C. Fitzgerald | 240 | 432 | 688 | 835 | 372 | 158 | 4.0k | |
| Roberto Pola | 468 | 476 | 1718 | 332 | 258 | 129 | 4.2k | |
| Leonardo Iaccarino | 52 | 461 | 428 | 352 | 570 | 103 | 2.8k | |
| Monika Baier | 800 | 194 | 552 | 665 | 718 | 60 | 4.4k | |
| Luca Durelli | 866 | 747 | 382 | 1684 | 924 | 113 | 4.1k | |
| Katherine Dawson | 803 | 628 | 889 | 750 | 658 | 32 | 3.4k | |
| Susan A. Burchill | 874 | 227 | 1427 | 952 | 129 | 79 | 3.6k | |
| Paolo Gallo | 553 | 475 | 1333 | 630 | 449 | 104 | 3.6k | |
| Mazen M. Dimachkie | 110 | 201 | 596 | 1581 | 393 | 159 | 3.1k | |
| Jacob Elkins | 313 | 613 | 206 | 708 | 300 | 75 | 3.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...